Pre-Open Movers:

Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) 113% HIGHER; signed an exclusive summary distribution agreement with Innovimed Sp. z o.o ("Innovimed"), a master distributor specializing in state-of-the-art medical solutions in Eastern Europe, Middle East and Africa. The Innovimed leadership team, have decades of experience with sales, marketing and distribution with medical devices in global healthcare industry companies including Baxter (AG).

Reata Pharmaceuticals, Inc. (Nasdaq: RETA) 41% LOWER; announced the outcome of the U.S. Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting on bardoxolone methyl (“bardoxolone”) for the treatment of patients with chronic kidney disease caused by Alport syndrome.

American Virtual Cloud Technologies, Inc. (Nasdaq: AVCT) 26.2% HIGHER; announced that it projects revenues of its Kandy Business Unit to grow from $14.3 million in 2020 to approximately $18.8 million in 2021 and in excess of $37 million in 2022. The significant projected growth is driven by 505% year-over-year subscriber growth (90% CAGR) from January 2019 to today.

RH (NYSE: RH) 10.8% HIGHER; reported Q3 EPS of $7.03, $0.39 better than the analyst estimate of $6.64. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $985.18 million. Now expect fiscal 2021 revenue growth of 32% to 33% versus our prior outlook of 31% to 33%, and adjusted operating margin in the range of 25.3% to 25.5% versus our prior outlook of 24.9% to 25.5%.

Relmada Therapeutics, Inc. (Nasdaq: RLMD) 10.4% LOWER; announced its intention to offer and sell $100 million of shares of its common stock in an underwritten public offering pursuant to its existing shelf registration statement.

RingCentral, Inc. (NYSE: RNG) 7% LOWER; announced that Anand Eswaran is stepping down from his role as President and Chief Operating Officer, and that Vaibhav Agarwal, the Companys Chief Accounting Officer, is appointed as the Interim Chief Financial Officer effective Jan. 1, 2022.

GameStop (NYSE: GME) 6% LOWER; reported Q3 EPS of ($1.39), $0.87 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.19 billion.

Lucid Group, Inc. (Nasdaq: LCID) 6.2% LOWER; announced its intention to offer, subject to market and other conditions, $1,750,000,000 aggregate principal amount of convertible senior notes due 2026 (the "notes") in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Lucid also expects to grant the initial purchasers of the notes an option, for settlement within a period of 13 days from, and including, the date the notes are first issued, to purchase up to an additional $262,500,000 principal amount of notes.

Streamline Health Solutions (NASDAQ: STRM) 5.6% HIGHER; reported Q3 EPS of ($0.10), $0.06 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $5.5 million versus the consensus estimate of $4.8 million.

Phreesia Inc. (NYSE: PHR) 5.6% LOWER; reported Q3 EPS of ($0.71), $0.35 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $55.9 million versus the consensus estimate of $48.71 million. Phreesia Inc. sees FY2022 revenue of $211 million, versus the consensus of $198 million.

Aptinyx (NASDAQ: APTX) 5.5% HIGHER; CEO, Norbert Riedel, bought 100,000 shares on 12/06 at $2.23.

Rent the Runway (NASDAQ: RENT) 4.4% LOWER; Reports Q3 Revenue of $59M, Adjusted EBITDA of $(5.6M), 116.8K Active Subscribers

UiPath Inc. (NYSE: PATH) 3.7% LOWER; Reports Q3 Revenue of $220.8M, EPS of $($0.23), Offers Guidance

JFrog (NASDAQ: FROG) 3.7% HIGHER; Stifel upgraded from Hold to Buy with a price target of $45.00.

Twilio (NYSE: TWLO) 3% HIGHER; Barclays upgraded from Equalweight to Overweight with a price target of $375.00.

UiPath Inc. (NYSE: PATH) 2.8% LOWER; reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $220.8 million versus the consensus estimate of $208.63 million. UiPath Inc. sees Q4 2022 revenue of $281-283 million, versus the consensus of $281.1 million.

Benson Hill, Inc. (NYSE: BHIL) 2.5% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $9.00.

Opiant Pharma (NASDAQ: OPNT) 2.4% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $42.00.

Janus Int'l Group, Inc. (NYSE: JBI) 1.8% HIGHER; Stifel initiates coverage with a Buy rating and a price target of $17.00.

Sportsmans Warehouse (NASDAQ: SPWH) 1% LOWER; reported Q3 EPS of $0.51, $0.03 worse than the analyst estimate of $0.54. Revenue for the quarter came in at $401 million versus the consensus estimate of $379.53 million.